eISSN: 2450-4459
ISSN: 2450-3517
Lekarz POZ
Current issue Archive Manuscripts accepted About the journal Abstracting and indexing Subscription Contact Instructions for authors
1/2018
vol. 4
 
Share:
Share:
more
 
 
abstract:
Review paper

Optimum β-adrenolytic drug in ischaemic heart disease – why is it worth choosing bisoprolol?

Marcin Barylski

Online publish date: 2018/03/12
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
Bisoprolol is one of the group of modern β-adrenolytics without vasodilator properties, being also a highly cardioselective drug. In contrast to third-generation β-adrenolytics (nebivolol, carvedilol), bisoprolol much more effectively and quickly reduces heart rate, so we should use it when we want more effective control of heart rate, which is extremely important in patients with ischaemic heart disease.
keywords:

β-adrenolytic drug, bisoprolol, ischaemic heart disease

Quick links
© 2019 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe